Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21;272(8):524.
doi: 10.1007/s00415-025-13276-w.

Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort

Francesca Palumbo #  1 , Barbara Iazzolino #  1 , Cristina Moglia #  1   2 , Umberto Manera  1   2 , Enrico Matteoni  1 , Sara Cabras  1 , Maura Brunetti  1 , Salvatore Gallone  2 , Stefano Callegaro  1 , Rosario Vasta  1 , Gabriele Mora  1 , Fabiola De Marchi  3   4 , Lucia Corrado  5 , Sandra D'Alfonso  5 , Letizia Mazzini  3   4 , Antonio Canosa  1   2   6 , Maurizio Grassano  1 , Andrea Calvo #  1   2 , Adriano Chiò #  7   8   9
Affiliations

Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort

Francesca Palumbo et al. J Neurol. .

Abstract

Background: Annexin A11 (ANXA11) has emerged as a significant gene associated with amyotrophic lateral sclerosis (ALS) and cognitive impairments. This study aimed to evaluate the prevalence and clinical and cognitive features of pathogenic variants in ANXA11 in an Italian ALS cohort.

Methods: Data were collected from the Piemonte and Valle d'Aosta Register for ALS between 2009 and 2020. Only patients who underwent whole genome sequencing (WGS) were included. Clinical and cognitive assessments were compared among patients with ANXA11-ALS, wild-type ALS (WT-ALS), and C9ORF72-ALS.

Results: Among 1,486 ALS patients, 18 (1.4%) were found to carry ANXA11 variants, four of which were classified as benign or likely benign. Three patients (16.7%) also had co-occurring variants in ERBB4 (erb-b2 receptor tyrosine kinase 4), EPHA4 (ephrin type-A receptor 4), or C9ORF72 (chromosome 9 open reading frame 72). Patients with ANXA11-ALS had significantly lower education levels (6.2 vs. 8.9 years), higher BMI at diagnosis (26.7 vs. 24.5), and a higher prevalence of cognitive impairment (100% vs. 47%) compared to WT-ALS. Cognitive testing revealed more severe deficits in executive function, attention, psychomotor speed, non-verbal intelligence, and cognitive flexibility, though no behavioral differences were observed. Compared to C9ORF72-ALS, ANXA11-ALS patients were older at diagnosis (66.6 vs. 60.3 years), had lower education levels (6.2 vs. 9.0 years), and higher rates of cognitive impairment (100% vs. 68.7%).

Discussion: Pathogenic ANXA11 variants are relatively common in ALS and are strongly associated with cognitive impairment. Including ANXA11 in routine genetic screening may enhance diagnostic precision and therapeutic strategies for ALS patients.

Keywords: ANXA11; Amyotrophic lateral sclerosis; Cognition; Phenotype.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Adriano Chiò serves on scientific advisory boards for Mitsubishi Tanabe, Biogen, Roche, Denali Pharma, Cytokinetics, Lilly, Ferrer, Zambon Biotech, and Amylyx Pharmaceuticals, and has received a research grant from Biogen. Francesca Palumbo, Barbara Iazzolino, Cristina Moglia, Umberto Manera, Enrico Matteoni, Sara Cabras, Maura Brunetti, Salvatore Gallone, Rosario Vasta, Gabriele Mora, Antonio Canosa, Maurizio Grassano do not report any conflict of interest. Andrea Calvo has received a research grant from Cytokinetics.

Figures

Fig. 1
Fig. 1
Schematics of the protein domain structure of ANXA11 and identified variants. LCD, low-complexity domain; ANX, ANX domain
See this image and copyright information in PMC

References

    1. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108. 10.1136/jnnp-2011-300188 - PubMed
    1. Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chiò A (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173. 10.1136/jnnp-2013-307223 - PubMed
    1. Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34(6):404–423. 10.1016/j.tig.2018.03.001 - PubMed
    1. Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, Miller JW, Sato A, Dias DM, Jeon M, Vance C, Wong CH, de Majo M, Kattuah W, Mitchell JC, Scotter EL, Parkin NW, Sapp PC, Nolan M, Nestor PJ, Simpson M, Weale M, Lek M, Baas F, Vianney de Jong JM, Ten Asbroek ALMA, Redondo AG, Esteban-Pérez J, Tiloca C, Verde F, Duga S, Leigh N, Pall H, Morrison KE, Al-Chalabi A, Shaw PJ, Kirby J, Turner MR, Talbot K, Hardiman O, Glass JD, De Belleroche J, Maki M, Moss SE, Miller C, Gellera C, Ratti A, Al-Sarraj S, Brown RH Jr, Silani V, Landers JE, Shaw CE (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med 9(388):eaad9157. 10.1126/scitranslmed.aad9157 - PMC - PubMed
    1. Wang J, Guo C, Liu S, Qi H, Yin Y, Liang R, Sun MZ, Greenaway FT (2014) Annexin A11 in disease. Clin Chim Acta 431:164–168. 10.1016/j.cca.2014.01.031 - PubMed